de Groen Max Pieter

SEC source: 0000950130-25-000308 · ownership.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,334

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2 · balance_after: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

SEC source: 0000950170-25-083859 · ownership.xml · nonDerivative · entry 2

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,355,285

F3 · kind: On June 5, 2025 BCPE Nucleon distributed 125,183 shares of Common Stock to one or more members or partners of BCPE Nucleon in connection with certain charitable gifts to be made by such members or partners or their direct or indirect owners.

F3 · price: On June 5, 2025 BCPE Nucleon distributed 125,183 shares of Common Stock to one or more members or partners of BCPE Nucleon in connection with certain charitable gifts to be made by such members or partners or their direct or indirect owners.

F1 · ownership.nature: Represents shares of the Issuer's common stock held directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon").

F2 · ownership.nature: Max de Groen is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, Mr. de Groen may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. Mr. de Groen disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000950170-25-083859 · ownership.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,480,468

F1 · ownership.nature: Represents shares of the Issuer's common stock held directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon").

F2 · ownership.nature: Max de Groen is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, Mr. de Groen may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. Mr. de Groen disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000950170-25-034020 · ownership.xml · nonDerivative · entry 2

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 10,960,935

F3 · kind: On March 4, 2025 BCPE Nucleon distributed 393,097 shares of Common Stock to one or more members or partners of BCPE Nucleon in connection with certain charitable gifts to be made by such members or partners or their direct or indirect owners.

F3 · price: On March 4, 2025 BCPE Nucleon distributed 393,097 shares of Common Stock to one or more members or partners of BCPE Nucleon in connection with certain charitable gifts to be made by such members or partners or their direct or indirect owners.

F1 · ownership.nature: Represents shares of the Issuer's common stock held directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon").

F2 · ownership.nature: Max de Groen is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, Mr. de Groen may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. Mr. de Groen disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000950170-25-034020 · ownership.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 11,354,032

F1 · ownership.nature: Represents shares of the Issuer's common stock held directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon").

F2 · ownership.nature: Max de Groen is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, Mr. de Groen may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. Mr. de Groen disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000950170-24-137433 · ownership.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,746

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2 · balance_after: The amount reported includes 3,646 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

SEC source: 0000950170-24-086215 · ownership.xml · derivative · entry 3

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 0

Underlying: Class A Common Stock · 16,854,032 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The conversion rate of 36.0360 per $1,000 principal amount of Convertible Notes is equivalent to an initial conversion price of $27.75 per share of Common Stock.

F5 · derivative.exercise_date: In accordance with an investment agreement, dated as of August 26, 2020, as amended on September 24, 2020, the BCPE Nucleon is restricted from converting the Convertible Notes prior to the earlier of (i) the date that is 12 months from the date of issuance and (ii) immediately prior to the consummation of any change of control of the Issuer or entry into a definitive agreement for a transaction that, if consummated, would result in a change in control of the Issuer or a fundamental change, in each case, subject to certain exceptions. Thereafter, the Convertible Notes are convertible at the option of the holder at any time until the close of business on the scheduled trading day immediately preceding the maturity date.

F6 · derivative.expiration_date: The Convertible Notes mature on September 15, 2026, subject to earlier redemption, repurchase or conversion in accordance with their terms.

F1 · ownership.nature: Represents shares of the Issuer's common stock acquired directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon") upon conversion of its $817,632,828 aggregate principal amount of 2.50% convertible notes due 2026, which was settled with $817,632,828 in cash on July 1, 2024 and, upon the expiration of the receipt of required regulatory approvals, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, which occurred on July 22, 2024, 16,854,032 shares of Class A common stock. In accordance with the indenture governing the notes, the conversion obligation was calculated based on a 25-trading day trailing volume-weighted average price of Class A common stock of approximately $65.51 per share, with the principal amount of the convertible notes settled in cash and the remainder settled in Class A common stock.

F2 · ownership.nature: Max de Groen is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, Mr. de Groen may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. Mr. de Groen disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000950170-24-086215 · ownership.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 16,854,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of the Issuer's common stock acquired directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon") upon conversion of its $817,632,828 aggregate principal amount of 2.50% convertible notes due 2026, which was settled with $817,632,828 in cash on July 1, 2024 and, upon the expiration of the receipt of required regulatory approvals, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, which occurred on July 22, 2024, 16,854,032 shares of Class A common stock. In accordance with the indenture governing the notes, the conversion obligation was calculated based on a 25-trading day trailing volume-weighted average price of Class A common stock of approximately $65.51 per share, with the principal amount of the convertible notes settled in cash and the remainder settled in Class A common stock.

F1 · ownership.nature: Represents shares of the Issuer's common stock acquired directly by BCPE Nucleon (DE) SPV, LP ("BCPE Nucleon") upon conversion of its $817,632,828 aggregate principal amount of 2.50% convertible notes due 2026, which was settled with $817,632,828 in cash on July 1, 2024 and, upon the expiration of the receipt of required regulatory approvals, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, which occurred on July 22, 2024, 16,854,032 shares of Class A common stock. In accordance with the indenture governing the notes, the conversion obligation was calculated based on a 25-trading day trailing volume-weighted average price of Class A common stock of approximately $65.51 per share, with the principal amount of the convertible notes settled in cash and the remainder settled in Class A common stock.

F2 · ownership.nature: Max de Groen is a Partner of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BCPE Nucleon. Voting and investment decisions with respect to securities held by BCPE Nucleon are made by the partners of BCI. As a result, Mr. de Groen may be deemed to share voting and dispositive power with respect to the securities held by BCPE Nucleon. Mr. de Groen disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

SEC source: 0000950170-23-069822 · ownership.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,100

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2 · balance_after: The amount reported includes the 6,088 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

SEC source: 0000899243-22-038333 · doc4.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,012

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2 · balance_after: The amount reported includes the 8,682 unvested RSUs referenced in footnote (1), which are issuable into shares of the Issuer's Class A common stock upon vesting.

SEC source: 0000899243-21-048142 · doc4.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,330

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2 · balance_after: The amount reported includes the 7,365 unvested RSUs referenced in footnote (1), which are issuable into shares of the Issuer's Class A common stock upon vesting.

SEC source: 0000899243-20-033772 · doc4.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,965

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2 · balance_after: The amount reported includes 11,839 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

SEC source: 0000899243-20-026387 · doc4.xml · nonDerivative · entry 1

de Groen Max Pieter · CIK 0001823512 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,126

F1 · shares: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.